TreeWAS – Variant ID: rs564036233

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N92.0 Excessive and frequent menstruation with regular cycle	0.000	0.009	0.991
N84.1 Polyp of cervix uteri	0.909	0.091	0.000
N80.1 Endometriosis of ovary	0.000	0.180	0.820
N80 Endometriosis	0.000	0.180	0.820
N80.9 Endometriosis, unspecified	0.000	0.202	0.798
N80.0 Endometriosis of uterus	0.000	0.244	0.756
N80.3 Endometriosis of pelvic peritoneum	0.000	0.251	0.749
N80.2 Endometriosis of Fallopian tube	0.000	0.307	0.693
N80.8 Other endometriosis	0.000	0.313	0.687
N80.6 Endometriosis in cutaneous scar	0.000	0.412	0.588
N80.4 Endometriosis of rectovaginal septum and vagina	0.000	0.494	0.506
N80.5 Endometriosis of intestine	0.000	0.494	0.506
N92 Excessive, frequent and irregular menstruation	0.000	0.592	0.408
N92.1 Excessive and frequent menstruation with irregular cycle	0.000	0.632	0.368
N80-N98 Noninflammatory disorders of female genital tract	0.000	0.641	0.359
N97 Female infertility	0.000	0.661	0.339
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.683	0.317
N83.0 Follicular cyst of ovary	0.000	0.686	0.314
N97.1 Female infertility of tubal origin	0.000	0.697	0.303
N97.9 Female infertility, unspecified	0.000	0.699	0.301
N86 Erosion and ectropion of cervix uteri	0.000	0.705	0.295
N92.2 Excessive menstruation at puberty	0.000	0.707	0.293
N89 Other noninflammatory disorders of vagina	0.000	0.733	0.267
N91 Absent, scanty and rare menstruation	0.000	0.736	0.264
N83.2 Other and unspecified ovarian cysts	0.000	0.738	0.262
N96 Habitual aborter	0.000	0.742	0.258
N98 Complications associated with artificial fertilisation	0.000	0.749	0.251
N82 Fistulae involving female genital tract	0.000	0.752	0.248
N97.4 Female infertility associated with male factors	0.000	0.757	0.243
N97.3 Female infertility of cervical origin	0.000	0.757	0.243
N97.2 Female infertility of uterine origin	0.000	0.757	0.243
N97.0 Female infertility associated with anovulation	0.000	0.757	0.243
N97.8 Female infertility of other origin	0.000	0.758	0.241
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.767	0.233
N89.6 Tight hymenal ring	0.000	0.772	0.228
N83.7 Haematoma of broad ligament	0.000	0.773	0.227
N83.6 Haematosalpinx	0.000	0.773	0.227
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.773	0.227
N89.5 Stricture and atresia of vagina	0.000	0.781	0.219
N84 Polyp of female genital tract	0.067	0.782	0.151
N91.2 Amenorrhoea, unspecified	0.000	0.790	0.210
N92.6 Irregular menstruation, unspecified	0.000	0.796	0.204
N91.5 Oligomenorrhoea, unspecified	0.000	0.803	0.197
N89.9 Noninflammatory disorder of vagina, unspecified	0.000	0.807	0.193
N82.0 Vesicovaginal fistula	0.000	0.807	0.193
N89.7 Haematocolpos	0.000	0.808	0.192
N89.4 Leukoplakia of vagina	0.000	0.808	0.192
N89.3 Dysplasia of vagina, unspecified	0.000	0.808	0.192
N89.2 Severe vaginal dysplasia, not elsewhere classified	0.000	0.808	0.192
N89.1 Moderate vaginal dysplasia	0.000	0.808	0.192
N89.0 Mild vaginal dysplasia	0.000	0.808	0.192
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.810	0.190
N91.4 Secondary oligomenorrhoea	0.000	0.810	0.189
N91.3 Primary oligomenorrhoea	0.000	0.810	0.189
N91.0 Primary amenorrhoea	0.000	0.810	0.189
N92.4 Excessive bleeding in the premenopausal period	0.000	0.811	0.189
N83.1 Corpus luteum cyst	0.000	0.813	0.187
N98.9 Complication associated with artificial fertilisation, unspecified	0.000	0.820	0.180
N98.8 Other complications associated with artificial fertilisation	0.000	0.820	0.180
N98.3 Complications of attempted introduction of embryo in embryo transfer	0.000	0.820	0.180
N98.2 Complications of attempted introduction of fertilised ovum following in vitro fertilisation	0.000	0.820	0.180
N98.0 Infection associated with artificial insemination	0.000	0.820	0.180
N82.8 Other female genital tract fistulae	0.000	0.822	0.178
N82.5 Female genital tract-skin fistulae	0.000	0.822	0.178
N82.2 Fistula of vagina to small intestine	0.000	0.822	0.178
N82.1 Other female urinary-genital tract fistulae	0.000	0.822	0.178
N82.9 Female genital tract fistula, unspecified	0.000	0.825	0.175
N98.1 Hyperstimulation of ovaries	0.000	0.827	0.173
N82.3 Fistula of vagina to large intestine	0.000	0.832	0.168
N82.4 Other female intestinal-genital tract fistulae	0.000	0.836	0.164
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.839	0.161
N91.1 Secondary amenorrhoea	0.000	0.840	0.159
N92.5 Other specified irregular menstruation	0.001	0.842	0.157
N84.9 Polyp of female genital tract, unspecified	0.040	0.843	0.117
N88 Other noninflammatory disorders of cervix uteri	0.000	0.844	0.156
N84.3 Polyp of vulva	0.038	0.846	0.115
N84.8 Polyp of other parts of female genital tract	0.047	0.849	0.105
N84.2 Polyp of vagina	0.036	0.858	0.106
N88.2 Stricture and stenosis of cervix uteri	0.000	0.881	0.119
N88.4 Hypertrophic elongation of cervix uteri	0.000	0.888	0.112
N88.3 Incompetence of cervix uteri	0.000	0.888	0.112
N88.0 Leukoplakia of cervix uteri	0.000	0.888	0.112
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.000	0.888	0.112
N88.1 Old laceration of cervix uteri	0.000	0.900	0.100
N90 Other noninflammatory disorders of vulva and perineum	0.000	0.902	0.098
N87 Dysplasia of cervix uteri	0.000	0.909	0.091
N90.4 Leukoplakia of vulva	0.000	0.916	0.083
N93 Other abnormal uterine and vaginal bleeding	0.000	0.918	0.082
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.000	0.919	0.081
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.924	0.076
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.000	0.930	0.070
N90.0 Mild vulvar dysplasia	0.000	0.930	0.070
N90.1 Moderate vulvar dysplasia	0.000	0.930	0.070
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.000	0.930	0.069
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.932	0.068
N87.1 Moderate cervical dysplasia	0.000	0.936	0.064
N87.2 Severe cervical dysplasia, not elsewhere classified	0.000	0.938	0.062
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.000	0.939	0.061
N90.6 Hypertrophy of vulva	0.000	0.945	0.054
N90.3 Dysplasia of vulva, unspecified	0.000	0.946	0.053
N94.6 Dysmenorrhoea, unspecified	0.000	0.951	0.049
N94.0 Mittelschmerz	0.000	0.954	0.046
N93.0 Postcoital and contact bleeding	0.000	0.954	0.046
N94.2 Vaginismus	0.000	0.956	0.044
N94.4 Primary dysmenorrhoea	0.000	0.957	0.042
N95 Menopausal and other perimenopausal disorders	0.000	0.957	0.042
N94.1 Dyspareunia	0.000	0.959	0.041
N85 Other noninflammatory disorders of uterus, except cervix	0.000	0.959	0.041
N93.8 Other specified abnormal uterine and vaginal bleeding	0.000	0.961	0.039
I12.0 Hypertensive renal disease with renal failure	0.000	0.962	0.038
N95.9 Menopausal and perimenopausal disorder, unspecified	0.000	0.964	0.036
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.000	0.964	0.036
N85.1 Endometrial adenomatous hyperplasia	0.000	0.965	0.035
N94.5 Secondary dysmenorrhoea	0.000	0.966	0.034
R07.3 Other chest pain	0.000	0.967	0.033
I12 Hypertensive renal disease	0.000	0.968	0.032
N87.9 Dysplasia of cervix uteri, unspecified	0.000	0.968	0.032
N85.7 Haematometra	0.000	0.970	0.030
N85.5 Inversion of uterus	0.000	0.970	0.030
N85.3 Subinvolution of uterus	0.000	0.970	0.030
I10-I15 Hypertensive diseases	0.000	0.972	0.028
N90.5 Atrophy of vulva	0.000	0.972	0.027
I10 Essential (primary) hypertension	0.000	0.972	0.028
N94.3 Premenstrual tension syndrome	0.000	0.973	0.027
N85.6 Intra-uterine synechiae	0.000	0.973	0.027
N85.9 Noninflammatory disorder of uterus, unspecified	0.000	0.973	0.027
N95.3 States associated with artificial menopause	0.000	0.974	0.026
N95.1 Menopausal and female climacteric states	0.000	0.974	0.025
N95.8 Other specified menopausal and perimenopausal disorders	0.000	0.976	0.024
N85.2 Hypertrophy of uterus	0.000	0.976	0.024
I11 Hypertensive heart disease	0.000	0.976	0.023
N92.3 Ovulation bleeding	0.002	0.977	0.021
I15 Secondary hypertension	0.000	0.978	0.022
I12.9 Hypertensive renal disease without renal failure	0.000	0.978	0.022
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.022	0.978	0.000
M06.9 Rheumatoid arthritis, unspecified	0.021	0.979	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.979	0.021
N85.0 Endometrial glandular hyperplasia	0.000	0.979	0.021
I13 Hypertensive heart and renal disease	0.000	0.979	0.020
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.020	0.980	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.981	0.019
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.019	0.981	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.982	0.018
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.018	0.982	0.000
N87.0 Mild cervical dysplasia	0.000	0.982	0.018
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.018	0.982	0.000
I15.1 Hypertension secondary to other renal disorders	0.000	0.982	0.018
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.018	0.982	0.000
I15.9 Seconday hypertension, unspecified	0.000	0.983	0.017
M06 Other rheumatoid arthritis	0.016	0.984	0.000
I15.8 Other secondary hypertension	0.000	0.984	0.016
I15.2 Hypertension secondary to endocrine disorders	0.000	0.984	0.016
I15.0 Renovascular hypertension	0.000	0.984	0.016
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.015	0.985	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.015	0.985	0.000
M06.4 Inflammatory polyarthropathy	0.015	0.985	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.985	0.015
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.985	0.015
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.985	0.015
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.985	0.015
N90.7 Vulvar cyst	0.001	0.986	0.014
M06.3 Rheumatoid nodule	0.013	0.987	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.013	0.987	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.013	0.987	0.000
E11.5 With peripheral circulatory complications	0.000	0.987	0.013
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.013	0.987	0.000
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.000	0.988	0.012
E11.9 Without complications	0.000	0.988	0.012
G40.9 Epilepsy, unspecified	0.000	0.988	0.012
M06.0 Seronegative rheumatoid arthritis	0.012	0.988	0.000
M06.8 Other specified rheumatoid arthritis	0.012	0.988	0.000
M06.2 Rheumatoid bursitis	0.012	0.988	0.000
M06.1 Adult-onset Still's disease	0.012	0.988	0.000
N85.4 Malposition of uterus	0.000	0.988	0.012
R07 Pain in throat and chest	0.000	0.988	0.012
M06.32 Rheumatoid nodule (Upper arm)	0.011	0.989	0.000
M06.48 Inflammatory polyarthropathy (Other)	0.011	0.989	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.011	0.989	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.011	0.989	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.011	0.989	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.011	0.989	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.011	0.989	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.011	0.989	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.011	0.989	0.000
K62.8 Other specified diseases of anus and rectum	0.000	0.989	0.011
R07.2 Precordial pain	0.000	0.989	0.011
M06.37 Rheumatoid nodule (Ankle and foot)	0.010	0.990	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.010	0.990	0.000
R07.1 Chest pain on breathing	0.000	0.990	0.010
M06.39 Rheumatoid nodule (Site unspecified)	0.010	0.990	0.000
M06.38 Rheumatoid nodule (Other)	0.010	0.990	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.010	0.990	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.010	0.990	0.000
M06.33 Rheumatoid nodule (Forearm)	0.010	0.990	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.010	0.990	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.010	0.990	0.000
G37.9 Demyelinating disease of central nervous system, unspecified	0.009	0.991	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.991	0.009
M06.34 Rheumatoid nodule (Hand)	0.009	0.991	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.009	0.991	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.009	0.991	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.009	0.991	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.009	0.991	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.009	0.991	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.009	0.991	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.009	0.991	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.009	0.991	0.000
M06.18 Adult-onset Still's disease (Other)	0.009	0.991	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.009	0.991	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.009	0.991	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.009	0.991	0.000
M06.14 Adult-onset Still's disease (Hand)	0.009	0.991	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.009	0.991	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.009	0.991	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.009	0.991	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.009	0.991	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.009	0.991	0.000
M06.28 Rheumatoid bursitis (Other)	0.009	0.991	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.009	0.991	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.009	0.991	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.009	0.991	0.000
M06.24 Rheumatoid bursitis (Hand)	0.009	0.991	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.009	0.991	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.009	0.991	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.009	0.991	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.009	0.991	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.009	0.991	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.009	0.991	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.009	0.991	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.009	0.991	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.009	0.991	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.009	0.991	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.009	0.991	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.009	0.991	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.009	0.991	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.009	0.991	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.008	0.992	0.000
N84.0 Polyp of corpus uteri	0.006	0.992	0.002
E11 Non-insulin-dependent diabetes mellitus	0.000	0.992	0.008
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.008	0.992	0.000
R07.0 Pain in throat	0.000	0.993	0.007
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.000	0.993	0.006
G40 Epilepsy	0.000	0.993	0.007
G40.8 Other epilepsy	0.000	0.993	0.006
E11.8 With unspecified complications	0.000	0.994	0.006
G82 Paraplegia and tetraplegia	0.006	0.994	0.000
N50.8 Other specified disorders of male genital organs	0.000	0.994	0.006
G82.2 Paraplegia, unspecified	0.006	0.994	0.000
G82.1 Spastic paraplegia	0.006	0.994	0.000
H18.8 Other specified disorders of cornea	0.000	0.994	0.006
E11.7 With multiple complications	0.000	0.994	0.006
G82.4 Spastic tetraplegia	0.006	0.994	0.000
E11.0 With coma	0.000	0.994	0.006
H35.8 Other specified retinal disorders	0.000	0.994	0.006
H35 Other retinal disorders	0.000	0.994	0.006
E11.2 With renal complications	0.000	0.994	0.006
H18 Other disorders of cornea	0.000	0.994	0.006
H35.7 Separation of retinal layers	0.000	0.994	0.006
G40.5 Special epileptic syndromes	0.000	0.994	0.005
H18.4 Corneal degeneration	0.000	0.995	0.005
Y85.0 Sequelae of motor-vehicle accident	0.005	0.995	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.000	0.995	0.005
H18.9 Disorder of cornea, unspecified	0.000	0.995	0.005
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.000	0.995	0.005
T50.9 Other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.000	0.995	0.005
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.000	0.995	0.005
H18.6 Keratoconus	0.000	0.995	0.005
N95.2 Postmenopausal atrophic vaginitis	0.000	0.995	0.005
G82.3 Flaccid tetraplegia	0.005	0.995	0.000
G82.0 Flaccid paraplegia	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
E11.6 With other specified complications	0.000	0.995	0.005
G82.5 Tetraplegia, unspecified	0.005	0.995	0.000
H18.1 Bullous keratopathy	0.000	0.995	0.005
S32.40 Fracture of acetabulum (closed)	0.005	0.995	0.000
H18.2 Other corneal oedema	0.000	0.995	0.005
H35.5 Hereditary retinal dystrophy	0.000	0.995	0.005
R21 Rash and other nonspecific skin eruption	0.005	0.995	0.000
X63.0 Home	0.005	0.995	0.000
X62.9 Unspecified place	0.005	0.995	0.000
G83 Other paralytic syndromes	0.004	0.996	0.000
E11.1 With ketoacidosis	0.000	0.996	0.004
H35.1 Retinopathy of prematurity	0.000	0.996	0.004
S32.4 Fracture of acetabulum	0.004	0.996	0.000
H35.2 Other proliferative retinopathy	0.000	0.996	0.004
G83.8 Other specified paralytic syndromes	0.004	0.996	0.000
N81.2 Incomplete uterovaginal prolapse	0.004	0.996	0.000
S32 Fracture of lumbar spine and pelvis	0.004	0.996	0.000
H18.7 Other corneal deformities	0.000	0.996	0.004
H18.3 Changes in corneal membranes	0.000	0.996	0.004
H18.0 Corneal pigmentations and deposits	0.000	0.996	0.004
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.004	0.996	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.004	0.996	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.000	0.996	0.004
T46 Poisoning by agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
H35.4 Peripheral retinal degeneration	0.000	0.996	0.004
S32.3 Fracture of ilium	0.004	0.996	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
G83.1 Monoplegia of lower limb	0.004	0.996	0.000
X60-X84 Intentional self-harm	0.004	0.996	0.000
G83.3 Monoplegia, unspecified	0.004	0.996	0.000
L43.9 Lichen planus, unspecified	0.000	0.996	0.004
S32.1 Fracture of sacrum	0.004	0.996	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.004	0.996	0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.004	0.996	0.000
S32.30 Fracture of ilium (closed)	0.004	0.996	0.000
S32.7 Multiple fractures of lumbar spine and pelvis	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
K25.7 Chronic without haemorrhage or perforation	0.000	0.996	0.004
S32.5 Fracture of pubis	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
G83.9 Paralytic syndrome, unspecified	0.004	0.996	0.000
G37 Other demyelinating diseases of central nervous system	0.004	0.996	0.000
H35.6 Retinal haemorrhage	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
T50.8 Diagnostic agents	0.004	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.004	0.996	0.000
T50.5 Appetite depressants	0.004	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.004	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.004	0.996	0.000
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
S32.10 Fracture of sacrum (closed)	0.004	0.996	0.000
E11.4 With neurological complications	0.000	0.996	0.004
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.004	0.996	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.000	0.996	0.003
H35.9 Retinal disorder, unspecified	0.000	0.996	0.003
S32.50 Fracture of pubis (closed)	0.004	0.996	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.000	0.996	0.003
G83.2 Monoplegia of upper limb	0.003	0.996	0.000
G83.5 Locked-in syndrome	0.003	0.997	0.000
G83.0 Diplegia of upper limbs	0.003	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
S32.41 Fracture of acetabulum (open)	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
S32.2 Fracture of coccyx	0.003	0.997	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.003	0.997	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.003	0.997	0.000
X78 Intentional self-harm by sharp object	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
X63.9 Unspecified place	0.003	0.997	0.000
X63.8 Other specified place	0.003	0.997	0.000
X63.7 Farm	0.003	0.997	0.000
X63.6 Industrial and construction area	0.003	0.997	0.000
X63.5 Trade and service area	0.003	0.997	0.000
X63.4 Street and highway	0.003	0.997	0.000
X63.3 Sports and athletics area	0.003	0.997	0.000
X63.2 School, other institution and public administrative area	0.003	0.997	0.000
X63.1 Residential institution	0.003	0.997	0.000
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)	0.003	0.997	0.000
X62.0 Home	0.003	0.997	0.000
X62.8 Other specified place	0.003	0.997	0.000
X62.7 Farm	0.003	0.997	0.000
X62.6 Industrial and construction area	0.003	0.997	0.000
X62.5 Trade and service area	0.003	0.997	0.000
X62.4 Street and highway	0.003	0.997	0.000
X62.3 Sports and athletics area	0.003	0.997	0.000
X62.2 School, other institution and public administrative area	0.003	0.997	0.000
X62.1 Residential institution	0.003	0.997	0.000
S82.50 Fracture of medial malleolus (closed)	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
S32.31 Fracture of ilium (open)	0.003	0.997	0.000
H33.2 Serous retinal detachment	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
H18.5 Hereditary corneal dystrophies	0.000	0.997	0.003
X65 Intentional self-poisoning by and exposure to alcohol	0.003	0.997	0.000
L29.9 Pruritus, unspecified	0.003	0.997	0.000
S32.11 Fracture of sacrum (open)	0.003	0.997	0.000
X84 Intentional self-harm by unspecified means	0.003	0.997	0.000
X83 Intentional self-harm by other specified means	0.003	0.997	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.003	0.997	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.003	0.997	0.000
X80 Intentional self-harm by jumping from a high place	0.003	0.997	0.000
X79 Intentional self-harm by blunt object	0.003	0.997	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.003	0.997	0.000
X76 Intentional self-harm by smoke, fire and flames	0.003	0.997	0.000
X75 Intentional self-harm by explosive material	0.003	0.997	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.003	0.997	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.003	0.997	0.000
X72 Intentional self-harm by handgun discharge	0.003	0.997	0.000
X71 Intentional self-harm by drowning and submersion	0.003	0.997	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.003	0.997	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.003	0.997	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
S32.71 Multiple fractures of lumbar spine and pelvis (open)	0.003	0.997	0.000
G80 Infantile cerebral palsy	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
S32.51 Fracture of pubis (open)	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
G37.5 Concentric sclerosis [Balo]	0.003	0.997	0.000
G37.4 Subacute necrotising myelitis	0.003	0.997	0.000
G37.2 Central pontine myelinolysis	0.003	0.997	0.000
G37.1 Central demyelination of corpus callosum	0.003	0.997	0.000
G37.0 Diffuse sclerosis	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.003	0.997	0.000
S32.81 Fracture of other and unspecified parts of lumbar spine and pelvis (open)	0.003	0.997	0.000
X60.8 Other specified place	0.003	0.997	0.000
G37.8 Other specified demyelinating diseases of central nervous system	0.003	0.997	0.000
X67.9 Unspecified place	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T79.3 Post-traumatic wound infection, not elsewhere classified	0.003	0.997	0.000
X60.2 School, other institution and public administrative area	0.003	0.997	0.000
X78.0 Home	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
X69.9 Unspecified place	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
S32.0 Fracture of lumbar vertebra	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.003	0.997	0.000
M19.11 Post-traumatic arthrosis of other joints (Shoulder region)	0.003	0.997	0.000
S32.21 Fracture of coccyx (open)	0.003	0.997	0.000
S32.20 Fracture of coccyx (closed)	0.003	0.997	0.000
G83.4 Cauda equina syndrome	0.003	0.997	0.000
X60.9 Unspecified place	0.003	0.997	0.000
X60.0 Home	0.003	0.997	0.000
X60.7 Farm	0.003	0.997	0.000
X60.6 Industrial and construction area	0.003	0.997	0.000
X60.5 Trade and service area	0.003	0.997	0.000
X60.4 Street and highway	0.003	0.997	0.000
X60.3 Sports and athletics area	0.003	0.997	0.000
X60.1 Residential institution	0.003	0.997	0.000
X69.0 Home	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
X67.8 Other specified place	0.002	0.997	0.000
X67.7 Farm	0.002	0.997	0.000
X67.6 Industrial and construction area	0.002	0.997	0.000
X67.5 Trade and service area	0.002	0.997	0.000
X67.4 Street and highway	0.002	0.997	0.000
X67.3 Sports and athletics area	0.002	0.997	0.000
X67.2 School, other institution and public administrative area	0.002	0.997	0.000
X67.1 Residential institution	0.002	0.997	0.000
X67.0 Home	0.002	0.997	0.000
X69.8 Other specified place	0.002	0.997	0.000
X69.7 Farm	0.002	0.997	0.000
X69.6 Industrial and construction area	0.002	0.997	0.000
X69.5 Trade and service area	0.002	0.997	0.000
X69.4 Street and highway	0.002	0.997	0.000
X69.3 Sports and athletics area	0.002	0.997	0.000
X69.2 School, other institution and public administrative area	0.002	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations